July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
A large-scale, epidemiologic study of the influence of ultraviolet exposure on myopia progression. - A 5-year follow-up study of approximately 57,000 Japanese patients' eyes. -
Author Affiliations & Notes
  • Masao Yoshida
    Department of Public Health, Kyorin University School of Medicine, Mitaka-shi, TOKYO, Japan
  • Nobuhisa Mizuki
    Department of Ophthalmology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
  • Masaki Takeuchi
    Department of Ophthalmology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
  • Takahiro Yamane
    Department of Ophthalmology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
  • Eiichi Okada
    Okada Eye Clinic, Yokohama, Kanagawa, Japan
  • Footnotes
    Commercial Relationships   Masao Yoshida, None; Nobuhisa Mizuki, None; Masaki Takeuchi, None; Takahiro Yamane, None; Eiichi Okada, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6347. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Masao Yoshida, Nobuhisa Mizuki, Masaki Takeuchi, Takahiro Yamane, Eiichi Okada; A large-scale, epidemiologic study of the influence of ultraviolet exposure on myopia progression. - A 5-year follow-up study of approximately 57,000 Japanese patients' eyes. -. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6347.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We undertook a 5-year large-scale epidemiologic study of approximately 57,000 eyes of Japanese patients, who had been prescribed soft contact lenses (SCL), with or without UV protection to correct ametropia. The purpose of this research was to clarify any effect ultraviolet exposure may have on the progression of myopia.

Methods : The subject of this study was the eyes of patients, in the 12 to 15 year age range, who were prescribed SCL at Okada Eye Clinic in Kanagawa, Japan, between 2002 and 2011. Patients were tracked over a 5-year period (between 2007 and 2016). From a total of 2,143,154 eyes: 1,211,608 were prescribed UV protected SCLs (UV+SCL); and 931,546 eyes were prescribed SCLs without UV protection (UV-SCL). The total number of eyes which were able to be tracked for 5 years was 57,135 (UV+S7CL: 35,734 eyes; and UV-SCL: 21,401 eyes). The subjects who had high myopia (S < -6.00) between the ages of 12 and 15 were excluded.

Results : First, analysis was conducted to measure changes in the degree of refraction over the 5 years. For men in UV+SCL this change was -1.106D; and in UV-SCL, -1.150D. The difference was slight but the progress of myopia in UV-SCL was significantly larger than in UV+SCL (P<0.001). For women in UV+SCL, this change was -1.127D; and in UV-SCL, -1.147D. As with men, the progress of myopia in UV-SCL was significantly greater than UV+SCL (P=0.025).
Furthermore, the power of the SCL initially prescribed at Okada Eye Clinic was checked and divided into 2 groups of myopia (medium myopia (-6.00D ≤ S < -3.00D); low myopia (-3.00D ≤ S < -0.25D)). Again the change in the degree of refraction over 5 years was analyzed.
For patients with medium myopia: in UV+SCL the change was -1.056D; in UV-SCL, -1.092D. For those with low myopia: in UV+SCL the change was -1.176D; in UV-SCL, -1.204D. For both degrees of myopia, myopia progression was significantly more rapid in UV-SCL compared to UV+SCL. (P<0.001, =0.005).

Conclusions : Through analysis of changes in the degree of refraction over 5 years by gender and myopic degree, it can be determined that in each instance, myopia progression with UV-SCL was significantly more rapid than with UV+SCL. From these results, it is suggested that ultraviolet exposure may be a risk factor in myopia progression.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×